Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution

Patients With ALS and Other Motor Discorders Will be Treated With Mesenchymal Cell Exosome Solution

Patients with ALS and other Motor Discorders will be treated with mesenchymal cell exosome solution.

Single Arm non-controlled study. Patients are prospectively evaluated then treated. Outcomes are tracked after treatment.

Inclusion Criteria:

• Patients will need a diagnosis established by a neurologist. Patients must be able to provide informed consent, or have a guardian who does. They must be able to travel to the site of treatment.

Exclusion Criteria:

• Patients were excluded from the trial if they were pregnant or had active cancer at the screening consultation.